Anaconda Biomed Receives IDE Approval to Initiate Enrollment in the ATHENA Study

by Ysios Capital

Anaconda Biomed S.L. has announced that it has received conditional IDE approval from the U.S. Food and Drug Administration to begin the ATHENA study of its ANA Funnel Catheter. The prospective, rando...

Read more

Avances hacia una medicina personalizada en las enfermedades mitocondriales gracias al análisis de nuevas variantes génicas

by Universidad Pablo de Olavide, de Sevilla

Un estudio del CABD identifica nuevas variantes genéticas del gen COQ7 y su relación con la deficiencia de Coenzima Q10 en pacientes pediátricos

Read more

Earth BioGenome project begins efforts to sequence 40 thousand genomes in the Catalan Countries

by Centre for Genomic Regulation

Sequencing the genomes of all plants, animals, and fungi on Earth—nearly two million known species—can protect biodiversity as we know it. This is the aim of the Earth Biogenome Project (Earth Bio...

Read more

ORYZON renueva su compromiso con la Alianza para la Vacunación Infantil

by Oryzon Genomics
  • 2 years ago

Oryzon suma su apoyo a la lucha contra la mortalidad infantil y contribuye al ODS 3 relativo a salud y bienestar promovido por las Naciones Unidas

Read more

What is Open Innovation in pharmaceutical R&D?

by GENESIS Biomed

The core idea of Open innovation is that companies leverage the ideas and resources of external actors such as customers, suppliers, universities, start-ups, etc.

Read more

La microbiota intestinal produce enzimas que inactivan las hormonas responsables del control de glucosa en sangre

by CSIC - Centro Superior de Investigaciones Científicas

Un estudio del Instituto de Agroquímica y Tecnología de Alimentos (CSIC) revela que ciertos microorganismos producen un homólogo que afecta al mecanismo que disminuye la glucosa en sangre

Read more

MicroRNA profiling as a biomarker to improve the management of patients with respiratory diseases proposed

by IRB Lleida. Institut de Recerca Biomèdica

MicroRNA (miRNA) profiles, small ribonucleic acid (RNA) sequences, may serve as innovative biomarkers to aid decision-making in the treatment of patients with respiratory diseases.

Read more

A study by IDIBELL and ICO proves the advantages of administering chemotherapy before surgery in stage II and III breast cancer

by IDIBELL - Institut d’Investigació Biomèdica de Bellvitge

The results, recently published in the journal Cancers, have been very optimistic: 25% of patients achieved a complete pathological response, especially HER2-positive patients (51%) and triple-negativ...

Read more

Children Living in Greener Neighbourhoods Show Better Lung Function

by ISGlobal - Instituto de Salud Global de Barcelona

A meta-analysis with 35,000 children from 8 European countries underscores the link between green urban spaces and respiratory health in childhood

Read more

More than 20 years with HIV under control without treatment: what we know about exceptional elite controllers

by IrsiCaixa

Less viral reservoir, a strong HIV-specific response, and defective viruses are some of the key factors that allow these individuals to control HIV, representing a great model of functional cure for t...

Read more

Researchers from CIC bioGUNE develop a 3D liver model with application in pharmaceutical industry for developing safer antitumoral drugs

by CIC bioGUNE

It has been developed an advanced three-dimensional model for the study of the interaction of primary healthy hepatocytes and tumor cells. This new model, published in the journal Biomedicines, enable...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Ona Therapeutics Raises $86.6 Million Se...

by Ysios Capital

Proceeds to support clinical development of lead first-in-class progra...

Photos Stream